Oxford Stemtech Ltd
Private Limited Company · London
ActiveUnited KingdomIncorporated 2020Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2025-03-31
IXBRL · 60 source facts · 16 selected values
Validation findingsXBRL valid
Accounts to 2025-03-31
IXBRL · 60 source facts · 16 selected values
Validation findings
XBRL valid
- Reporting period
- 2024-04-01 to 2025-03-31
- Extraction status
- complete
- Numeric facts
- 16
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- invalid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2023-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2510_12419218_20250331
- Source archive
- Accounts_Monthly_Data-October2025.zip
Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.
Accounts to 2024-03-31
IXBRL · 45 source facts · 16 selected values
Not assessedlegacy record
Accounts to 2024-03-31
IXBRL · 45 source facts · 16 selected values
Not assessed
legacy record
- Reporting period
- 2023-04-01 to 2024-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 16
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2023-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_3000_12419218_20240331
- Source archive
- Accounts_Monthly_Data-October2024.zip
Accounts to 2023-03-31
IXBRL · 45 source facts · 16 selected values
Not assessedlegacy record
Accounts to 2023-03-31
IXBRL · 45 source facts · 16 selected values
Not assessed
legacy record
- Reporting period
- 2022-04-01 to 2023-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 16
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2023-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_6666_12419218_20230331
- Source archive
- Accounts_Monthly_Data-December2023.zip
Accounts to 2022-03-31
IXBRL · 45 source facts · 16 selected values
Not assessedlegacy record
Accounts to 2022-03-31
IXBRL · 45 source facts · 16 selected values
Not assessed
legacy record
- Reporting period
- 2021-04-01 to 2022-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 16
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0109_12419218_20220331
- Source archive
- Accounts_Monthly_Data-August2022.zip
Accounts to 2021-03-31
IXBRL · 32 source facts · 10 selected values
Not assessedlegacy record
Accounts to 2021-03-31
IXBRL · 32 source facts · 10 selected values
Not assessed
legacy record
- Reporting period
- 2020-01-22 to 2021-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 13
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0095_12419218_20210331
- Source archive
- Accounts_Monthly_Data-October2021.zip
Registered details
12419218- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2020-01-22
- Jurisdiction
- —
- Registered office
- 71-75, SHELTON STREET, LONDON, WC2H 9JQ, ENGLAND
Classification
1 SIC codes23103
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
1 matched grantsParallelised ultra high-density electrophysiological assays to power epilepsy precision medicineLeadLiveInnovate UK · CR&D Bilateral · 2024-12-01 – 2027-03-31 · with 1 other participant£222,758awarded
Parallelised ultra high-density electrophysiological assays to power epilepsy precision medicineLeadLive
Innovate UK · CR&D Bilateral · 2024-12-01 – 2027-03-31 · with 1 other participant
£222,758
awarded
Oxford Stemtech Ltdlead£222,758